US patent
Rhelion Adds U.S. Patent to PEX010 Psilocybin Platform
Rhelion Life Sciences Corp. (CSE: RHEL; OTCQB: TRUFF; FSE: 4YX0) announced on August 27, 2026, that its wholly owned subsidiary Filament Health added a new U.S. patent covering a natural-source psychoactive alkaloid extraction process. U.S. Patent No. 12,697,564, titled “Dephosphorylation-Controlled Extraction of Phosphorylatable Psychoactive Alkaloids,” was issued on August 4. The patent names Filament subsidiary…
